Cargando…
Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection Without Mutations in the Spike Protein
Autores principales: | Kulkarni, Onkar, Narreddy, Suneetha, Zaveri, Lamuk, Kalal, Irawathy Goud, Tallapaka, Karthik Bharadwaj, Sowpati, Divya Tej |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7929054/ https://www.ncbi.nlm.nih.gov/pubmed/34492695 http://dx.doi.org/10.1093/cid/ciab136 |
Ejemplares similares
-
Clinical outcomes in individuals hospitalized with SARS-CoV-2 Delta variant (B.1.617.2) who had been vaccinated with Covishield (ChAdOx1) and Covaxin (BBV-152)
por: Munigela, Apoorva, et al.
Publicado: (2022) -
A Distinct Phylogenetic Cluster of Indian Severe Acute Respiratory Syndrome Coronavirus 2 Isolates
por: Banu, Sofia, et al.
Publicado: (2020) -
Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2: What Goes Around May Come Back Around
por: Kim, Arthur Y, et al.
Publicado: (2020) -
Assessment of the Risk of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection in an Intense Reexposure Setting
por: Abu-Raddad, Laith J, et al.
Publicado: (2020) -
Reinfection With SARS-CoV-2: Implications for Vaccines
por: Cohen, Jeffrey I, et al.
Publicado: (2020)